Attributable costs of patients with candidemia and potential implications of polymerase chain reaction-based pathogen detection on antifungal therapy in patients with sepsis

Journal of Critical Care

Volumn 28, Issue 1, 2013, Pages 2-8

  Bloos, Frank ^a   Bayer, Ole ^a   Sachse, Svea ^a   Straube, Eberhard ^a   Reinhart, Konrad ^a   Kortgen, Andreas ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Antifungal agents; Candidemia; Costs and cost analysis; Propensity score

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CATECHOLAMINE;

AGED; ARTICLE; ASPERGILLUS FUMIGATUS; BLOOD ANALYSIS; BLOOD CULTURE; CANDIDA KRUSEI; CANDIDEMIA; CANDIDIASIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HOSPITAL MANAGEMENT; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MICROORGANISM DETECTION; MULTIPLEX POLYMERASE CHAIN REACTION; OBSERVATIONAL STUDY; PATIENT CARE; POLYMERASE CHAIN REACTION; PROPENSITY SCORE; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS;

AGED; ANTIFUNGAL AGENTS; CANDIDEMIA; CASE-CONTROL STUDIES; COSTS AND COST ANALYSIS; DELAYED DIAGNOSIS; FEMALE; GERMANY; HEALTH CARE COSTS; HUMANS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MATCHED-PAIR ANALYSIS; MULTIPLEX POLYMERASE CHAIN REACTION; PROPENSITY SCORE; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; TIME FACTORS;

EID: 84870783817     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.07.011     Document Type: Article

References (28)

1. Pfaller M.A., Diekema D.J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007, 20:133-163.
2. Bougnoux M.E., Kac G., Aegerter P., et al. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med 2008, 34:292-299.
3. Luzzati R., Allegranzi B., Antozzi L., et al. Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital. Clin Microbiol Infect 2005, 11:908-913.
4. Meersseman W., Lagrou K., Spriet I., et al. Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med 2009, 35:1526-1531.
5. Leroy O., Gangneux J.P., Montravers P., et al. Epidemiology, management, and risk factors for death of invasive candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 2009, 37:1612-1618.
6. Guery B.P., Arendrup M.C., Auzinger G., et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part II. Treatment. Intensive Care Med 2009, 35:206-214.
7. Blumberg H.M., Jarvis W.R., Soucie J.M., et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001, 33:177-186.
8. Finfer S., Bellomo R., Lipman J., et al. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 2004, 30:589-596.
9. Richards M., Thursky K., Buising K. Epidemiology, prevalence, and sites of infections in intensive care units. Semin Respir Crit Care Med 2003, 24:3-22.
10. Garey K.W., Rege M., Pai M.P., et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 2006, 43:25-31.
11. Morrell M., Fraser V.J., Kollef M.H. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005, 49:3640-3645.
12. Patel G.P., Simon D., Scheetz M., et al. The effect of time to antifungal therapy on mortality in candidemia associated septic shock. Am J Ther 2009, 16:508-511.
13. Ostrosky-Zeichner L. Prophylaxis and treatment of invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2004, 23:739-744.
14. Pelz R.K., Hendrix C.W., Swoboda S.M., et al. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001, 233:542-548.
15. Shan Y.S., Sy E.D., Wang S.T., et al. Early presumptive therapy with fluconazole for occult candida infection after gastrointestinal surgery. World J Surg 2006, 30:119-126.
16. Bloos F., Hinder F., Becker K., et al. A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis. Intensive Care Med 2010, 36:241-247.
17. Avni T., Leibovici L., Paul M. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol 2011, 49:665-670.
18. Hebart H., Klingspor L., Klingebiel T., et al. A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT. Bone Marrow Transplant 2009, 43:553-561.
19. Olaechea P.M., Palomar M., Leon-Gil C., et al. Economic impact of candida colonization and candida infection in the critically ill patient. Eur J Clin Microbiol Infect Dis 2004, 23:323-330.
20. Rentz A.M., Halpern M.T., Bowden R. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis 1998, 27:781-788.
21. Sachse S., Straube E., Lehmann M., et al. Truncated human cytidylate-phosphate-deoxyguanylate-binding protein for improved nucleic acid amplification technique-based detection of bacterial species in human samples. J Clin Microbiol 2009, 47:1050-1057.
22. Moerer O., Schmid A., Hofmann M., et al. Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use. Intensive Care Med 2002, 28:1440-1446.
23. Dubberke E.R., Reske K.A., Olsen M.A., et al. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis 2008, 46:497-504.
24. R Development Core Team R: A language and environment for statistical computing 2008, R Foundation for Statistical Computing, Vienna.
25. Landlinger C., Preuner S., Baskova L., et al. Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in immunocompromised pediatric patients. Leukemia 2010, 24:2032-2038.
26. Nguyen M.H., Wissel M.C., Shields R.K., et al. Performance of candida real-time polymerase chain reaction, beta-d-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 2012, 54:1240-1248.
27. Lehmann L.E., Herpichboehm B., Kost G.J., et al. Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials. Crit Care 2010, 14:R186.
28. Fitting C., Parlato M., Adib-Conquy M., et al. DNAemia detection by multiplex PCR and biomarkers for infection in systemic inflammatory response syndrome patients. PLoS One 2012, 7:e38916.